Search
for
Sort by
Research 30 of 137
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- Oral tofacitinib: a promising treatment in atopic dermatitis, alopecia areata and vitiligo
- Case Report: Baricitinib improved alopecia areata in a pediatric patient with atopic dermatitis
- Successful treatment of severe atopic dermatitis and alopecia universalis with upadacitinib in a 29-year-old male patient
- Netherton syndrome: effect on ichthyosis linearis circumflexa with dupilumab
- Features of the clinical course of the disease, quality of life and systemic cytokine profile in patients with chronic true eczema and depression
- Allergen‐specific immunotherapy improves alopecia totalis in a severe atopic dermatitis patient
- Long‐Term Use of Tralokinumab in Patients With Atopic Dermatitis: A Real‐World Multicentric Case Series
- Skin image analysis for detection and quantitative assessment of dermatitis, vitiligo and alopecia areata lesions: a systematic literature review
- Dupilumab Alters Both the Bacterial and Fungal Skin Microbiomes of Patients with Atopic Dermatitis
- Nemolizumab Treatment for Severe Atopic Dermatitis Led to the Simultaneous Improvement of Coexisting Refractory Alopecia Areata: A Case Report
- 170 Forecasting Phase 3 Dose-Response for Abrocitinib, an Oral Janus Kinase 1 Selective Inhibitor, Using Investigator’s Global Assessment and Eczema Area and Severity Index
- 608 A clinical study to test the efficacy of VB1953 in clindamycin non-responder acne patients with antibiotic-resistant P. acnes
- Efficacy of Upadacitinib in Treating Alopecia Areata, Atopic Dermatitis, and Th1 Comorbidities in Pediatric Patients: A Comprehensive Case Series and Literature Review
- Standardized classification tools in dermatology: time to focus on cutaneous warts
- Adherence to topical hydrocortisone 17-butyrate 0.1% in different vehicles in adults with atopic dermatitis
- A Study of the Accuracy and Reliability of Articles about Alopecia in Newspapers
- Dupilumab induces hair regrowth in pediatric alopecia areata: a real-world, single-center observational study
- Making sense of measures of clinical signs for atopic dermatitis
- Human umbilical cord mesenchymal stem cell treatment alleviates symptoms in an atopic dermatitis-like mouse model
- JAK inhibition decreases the autoimmune burden in Down syndrome
- Mesenchymal stem/stromal cell therapy in atopic dermatitis and chronic urticaria: immunological and clinical viewpoints
- JAK inhibition decreases the autoimmune burden in Down syndrome
- Lichen Planus Activity and Damage Index (LiPADI)–Creation of the Questionnaire
- JAK1 Signaling Is Involved in the Induction of Mechanical Alloknesis in Atopic Dermatitis
- Regulatory pathways implicated in male androgenetic alopecia pathogenesis
- Alopecia: the questions we need to answer
- Efficacy of Dupilumab in Patients with Atopic Dermatitis and Alopecia Areata: A Case Series
- 605 Efficacy and safety of dupilumab in adolescent patients with moderate-to-severe atopic dermatitis
- 609 Topical Sandalore®, a specific OR2AT4-stimulating odorant, ameliorates female telogen effluvium: Randomized, double-blinded, placebo-controlled clinical trial